ivWatch and Marathon sign distribution deal for patient monitoring tech
Through this partnership, ivWatch products will be integrated into Marathon's FSS/GSA contracts.
25 October 2023
25 October 2023
Through this partnership, ivWatch products will be integrated into Marathon's FSS/GSA contracts.
The FDA has granted an IDE for a trial investigating the FlexHD in breast reconstruction, despite the agency previously implicating a higher risk profile for the device when used off-label.
The approval marks the first FDA clearance from VUNO’s AI portfolio, as automated technology grows in medical imaging.
A panel discussion at a Copenhagen conference saw representatives from sponsor organisations sharing their hopes for CROs to take ownership when trials go wrong.
The REAL-PE study assessed information sourced from Truveta, which has access to EHR data from over 30 US healthcare systems.
The trilogy transcatheter heart valve system met the non-inferiority criteria for the primary safety and efficacy endpoints in the ALIGN-AR trial.
Sponsors have been encouraged to keep their reputations above water and stave off bureaucratic slowdown to clinical trials by meeting clinicians face to face.
The trial’s co-primary endpoints comprise HCC tumours’ response rates and duration of response from Eye90 treatment.
Although metaverse technologies could reinvent healthcare approaches and bring new experiences to healthcare providers and patients, adoption is still at an early stage. There are currently few use cases in the healthcare industry. The metaverse needs to overcome major challenges for healthcare, including regulation and data privacy concerns. Evidence of proven use cases and participation by a critical mass of users are imperative to drive a shift in metaverse investment.
The Excellence Awards celebrate the greatest achievements and innovations in the industry while providing a platform to recognize the people and companies driving change – get entry details now.
Give your business an edge with our leading industry insights.